These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 37439850)

  • 1. Position statement on infection screening, prophylaxis, and vaccination in pediatric patients with rheumatic diseases and immunosuppressive therapies, part 2: infection prophylaxis.
    Clemente Garulo D; Núñez-Cuadros E; Camacho Lovillo M; Calzada-Hernández J; Guillén Martín S; Fernández Silveira L; Lirola Cruz MJ; Tagarro A; Alcobendas Rueda RM; López López A; Satrustegi Aritziturri M; Calvo C
    Eur J Pediatr; 2023 Sep; 182(9):4271-4284. PubMed ID: 37439850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Position statement on infection screening, prophylaxis, and vaccination of pediatric patients with rheumatic diseases and immunosuppressive therapies, part 3: precautions in situations of surgery, fever, and opportunistic infections.
    Clemente D; Cuadros EN; Lovillo MC; Hernández JC; Martín SG; Silveira LF; Cruz MJL; Tagarro A; Rueda RMA; López López A; Aritziturri MS; Calvo C
    Eur J Pediatr; 2024 Feb; 183(2):915-927. PubMed ID: 38047962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Position statement of the Spanish Society of Pediatric Rheumatology on infection screening, prophylaxis, and vaccination of pediatric patients with rheumatic diseases and immunosuppressive therapies: Part 1 (screening).
    Cuadros EN; Calzada-Hernández J; Clemente D; Martín SG; Silveira LF; Lirola-Cruz MJ; Tagarro A; Lovillo MC; Rueda RMA; López AL; Aritziturri MS; Calvo C
    Eur J Pediatr; 2022 Jun; 181(6):2343-2354. PubMed ID: 35258699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consensus of the Spanish society of pediatric rheumatology for transition management from pediatric to adult care in rheumatic patients with childhood onset.
    Calvo I; Antón J; Bustabad S; Camacho M; de Inocencio J; Gamir ML; Graña J; La Cruz L; Robledillo JC; Medrano M; Merino R; Modesto C; Nuñez E; Rua MJ; Torrente-Segarra V; Vargas C; Carmona L; Loza E
    Rheumatol Int; 2015 Oct; 35(10):1615-24. PubMed ID: 25917856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines on COVID-19 vaccination in patients with immune-mediated rheumatic diseases: a Brazilian Society of Rheumatology task force.
    Tavares ACFMG; de Melo AKG; Cruz VA; de Souza VA; de Carvalho JS; Machado KLLL; de Azevedo Valadares LD; Dos Reis Neto ET; de Rezende RPV; de Resende Guimarães MFB; Ferreira GA; de Sousa Braz A; de Abreu Vieira RMR; de Medeiros Pinheiro M; Ribeiro SLE; Bica BEGR; Baptista KL; da Costa IP; Marques CDL; Lopes MLL; Martinez JE; Giorgi RDN; da Mota LMH; da Rocha Loures MAA; Dos Santos Paiva E; Monticielo OA; Xavier RM; Kakehasi AM; Pileggi GCS
    Adv Rheumatol; 2022 Jan; 62(1):3. PubMed ID: 35039077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical course and therapeutic approach to varicella zoster virus infection in children with rheumatic autoimmune diseases under immunosuppression.
    Leuvenink R; Aeschlimann F; Baer W; Berthet G; Cannizzaro E; Hofer M; Kaiser D; Schroeder S; Heininger U; Woerner A
    Pediatr Rheumatol Online J; 2016 Jun; 14(1):34. PubMed ID: 27256096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of infections in rheumatic patients receiving biological therapies. The Portuguese Society of Rheumatology recommendations.
    Teixeira L; Fonseca AR; Eugénio G; Rodrigues M; Khmelinskii N; Fernandes S; Serra S; Costa T; Santos MJ
    Acta Reumatol Port; 2016; 41(4):287-304. PubMed ID: 27680031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring, prophylaxis, and treatment of infections in patients with MM receiving bispecific antibody therapy: consensus recommendations from an expert panel.
    Raje N; Anderson K; Einsele H; Efebera Y; Gay F; Hammond SP; Lesokhin AM; Lonial S; Ludwig H; Moreau P; Patel K; Ramasamy K; Mateos MV
    Blood Cancer J; 2023 Aug; 13(1):116. PubMed ID: 37528088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommendations for Vaccination in Adult Patients with Systemic Inflammatory Rheumatic Diseases from the Portuguese Society of Rheumatology.
    Cordeiro I; Duarte AC; Ferreira JF; Gonçalves MJ; Meirinhos T; Rocha TM; Romão VC; Sousa S; Guedes M; Conde M; Abreu C; Aleixo MJ; Santos MJ
    Acta Reumatol Port; 2016; 41(2):112-30. PubMed ID: 27606471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of vaccinations and prophylaxis in rheumatic diseases.
    Papadopoulou D; Tsoulas C; Tragiannidis A; Sipsas NV
    Best Pract Res Clin Rheumatol; 2015 Apr; 29(2):306-18. PubMed ID: 26362746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is cotrimoxazole prophylaxis against Pneumocystis jirovecii pneumonia needed in patients with systemic autoimmune rheumatic diseases requiring immunosuppressive therapies?
    Pereda CA; Nishishinya-Aquino MB; Brito-García N; Díaz Del Campo Fontecha P; Rua-Figueroa I
    Rheumatol Int; 2021 Aug; 41(8):1419-1427. PubMed ID: 33656582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases.
    Fragoulis GE; Nikiphorou E; Dey M; Zhao SS; Courvoisier DS; Arnaud L; Atzeni F; Behrens GM; Bijlsma JW; Böhm P; Constantinou CA; Garcia-Diaz S; Kapetanovic MC; Lauper K; Luís M; Morel J; Nagy G; Polverino E; van Rompay J; Sebastiani M; Strangfeld A; de Thurah A; Galloway J; Hyrich KL
    Ann Rheum Dis; 2023 Jun; 82(6):742-753. PubMed ID: 36328476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
    Wharton M; Strikas RA; Harpaz R; Rotz LD; Schwartz B; Casey CG; Pearson ML; Anderson LJ; ;
    MMWR Recomm Rep; 2003 Apr; 52(RR-7):1-16. PubMed ID: 12710832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases.
    Bass AR; Chakravarty E; Akl EA; Bingham CO; Calabrese L; Cappelli LC; Johnson SR; Imundo LF; Winthrop KL; Arasaratnam RJ; Baden LR; Berard R; Bridges SL; Cheah JTL; Curtis JR; Ferguson PJ; Hakkarinen I; Onel KB; Schultz G; Sivaraman V; Smith BJ; Sparks JA; Vogel TP; Williams EA; Calabrese C; Cunha JS; Fontanarosa J; Gillispie-Taylor MC; Gkrouzman E; Iyer P; Lakin KS; Legge A; Lo MS; Lockwood MM; Sadun RE; Singh N; Sullivan N; Tam H; Turgunbaev M; Turner AS; Reston J
    Arthritis Care Res (Hoboken); 2023 Mar; 75(3):449-464. PubMed ID: 36597813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction to: Position statement of the Spanish society of pediatric rheumatology on infection screening, prophylaxis, and vaccination of pediatric patients with rheumatic diseases and immunosuppressive therapies: part 1 (screening).
    Núñez Cuadros E; Calzada-Hernández J; Clemente D; Martín SG; Fernández Silveira L; Lirola-Cruz MJ; Tagarro A; Camacho Lovillo M; Alcobendas Rueda RM; López López A; Satrustegi Aritziturri M; Calvo C
    Eur J Pediatr; 2022 Jun; 181(6):2355. PubMed ID: 35307769
    [No Abstract]   [Full Text] [Related]  

  • 17. 2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases.
    Bass AR; Chakravarty E; Akl EA; Bingham CO; Calabrese L; Cappelli LC; Johnson SR; Imundo LF; Winthrop KL; Arasaratnam RJ; Baden LR; Berard R; Bridges SL; Cheah JTL; Curtis JR; Ferguson PJ; Hakkarinen I; Onel KB; Schultz G; Sivaraman V; Smith BJ; Sparks JA; Vogel TP; Williams EA; Calabrese C; Cunha JS; Fontanarosa J; Gillispie-Taylor MC; Gkrouzman E; Iyer P; Lakin KS; Legge A; Lo MS; Lockwood MM; Sadun RE; Singh N; Sullivan N; Tam H; Turgunbaev M; Turner AS; Reston J
    Arthritis Rheumatol; 2023 Mar; 75(3):333-348. PubMed ID: 36597810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [I]: anti-tumor necrosis factor-α agents).
    Baddley JW; Cantini F; Goletti D; Gómez-Reino JJ; Mylonakis E; San-Juan R; Fernández-Ruiz M; Torre-Cisneros J
    Clin Microbiol Infect; 2018 Jun; 24 Suppl 2():S10-S20. PubMed ID: 29459143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52).
    Mikulska M; Lanini S; Gudiol C; Drgona L; Ippolito G; Fernández-Ruiz M; Salzberger B
    Clin Microbiol Infect; 2018 Jun; 24 Suppl 2():S71-S82. PubMed ID: 29447988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EULAR/PRES recommendations for vaccination of paediatric patients with autoimmune inflammatory rheumatic diseases: update 2021.
    Jansen MHA; Rondaan C; Legger GE; Minden K; Uziel Y; Toplak N; Maritsi D; van den Berg L; Berbers GAM; Bruijning P; Egert Y; Normand C; Bijl M; Foster HE; Koné-Paut I; Wouters C; Ravelli A; Elkayam O; Wulffraat NM; Heijstek MW
    Ann Rheum Dis; 2023 Jan; 82(1):35-47. PubMed ID: 35725297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.